Tag: Kevzara (sarilumab)

Sanofi

Sanofi and Regeneron provide update on Kevzara Phase 3 Covid-19 trials

0
Sanofi and Regeneron Pharmaceuticals announced that the US Phase 3 trial of Kevzara (sarilumab) 400 mg in Covid-19 patients requiring mechanical ventilation did not...

This function has been disabled for HealthTekPak.

error: Content is protected !!